# Immunovant, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:475a2678-8a75-462d-b44c-64017cac3e77 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/immunovant-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 20 |
| Claims under review | 1 |
| Evidence records | 6 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-21T04:45:40.96006+00:00 |
| Last reviewed | 2026-10-21T04:45:40.96006+00:00 |

## Identity

- Legal name: Immunovant, Inc.
- Display name: Immunovant, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-21T21:41:21.366861+00:00 |
| Completeness | 0.364 |
| Record Quality | 0.814 |
| Directors | 6 |
| Committees | 0 |
| Governance events | 4 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | NOT_REVIEWED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Andrew Fromkin: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:7
- Atul Pande: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:8
- Douglas Hughes: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:9
- Frank M. Torti: Executive Chairperson of the Board. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:6
- Jacob Bauer: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:10
- Robert Susman: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:11

## Executive leadership

- Eric Venker, M.D., Pharm.D.: Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:14
- Jay S. Stout, Ph.D.: Chief Technology Officer [CTO]. Status: current. claim_id=alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:16
- Michael Geffner, M.D.: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:18
- Tiago Girao: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:19
- Christopher Van Tuyl: Chief Legal Officer and Corporate Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:12
- Eric Venker: Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:13
- Jay S. Stout: Chief Technology Officer [CTO]. Status: unknown. claim_id=alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:15
- Melanie Gloria: Chief Operating Officer [COO]. Status: unknown. claim_id=alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:17
- Tiago Girão: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:20

## Governance events

- CEO_CHANGED: Eric Venker, M.D., Pharm.D. executive of Immunovant, Inc., effective 2025-07-09. Effective: 2025-07-09. Detected: 2026-10-21T04:45:40.96006+00:00. event_id=alpha:event:transition:h6kklf53cw8t
- EXECUTIVE_APPOINTED: Jay S. Stout, Ph.D. executive of Immunovant, Inc., effective 2025-07-09. Effective: 2025-07-09. Detected: 2026-10-21T04:45:40.96006+00:00. event_id=alpha:event:transition:1wf48wa1q1oqek
- EXECUTIVE_APPOINTED: Michael Geffner, M.D. executive of Immunovant, Inc., effective 2025-07-09. Effective: 2025-07-09. Detected: 2026-10-21T04:45:40.96006+00:00. event_id=alpha:event:transition:1aia9m21jr9bj0
- CFO_CHANGED: Tiago Girao executive of Immunovant, Inc., effective 2025-07-09. Effective: 2025-07-09. Detected: 2026-10-21T04:45:40.96006+00:00. event_id=alpha:event:transition:apow5nni6de9

## Scoped resources

- `alpha://company/immunovant-inc` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record
- `alpha://company/immunovant-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=identity
- `alpha://company/immunovant-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=corporate-structure
- `alpha://company/immunovant-inc/board` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=board
- `alpha://company/immunovant-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=committees
- `alpha://company/immunovant-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=leadership
- `alpha://company/immunovant-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=ownership
- `alpha://company/immunovant-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=financials
- `alpha://company/immunovant-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=capital-structure
- `alpha://company/immunovant-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=compensation
- `alpha://company/immunovant-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=governance
- `alpha://company/immunovant-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=shareholder-governance
- `alpha://company/immunovant-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=audit
- `alpha://company/immunovant-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=legal
- `alpha://company/immunovant-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=risk
- `alpha://company/immunovant-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=cyber
- `alpha://company/immunovant-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=ai-governance
- `alpha://company/immunovant-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=agents
- `alpha://company/immunovant-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=ecosystem
- `alpha://company/immunovant-inc/events` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=events
- `alpha://company/immunovant-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=relationships
- `alpha://company/immunovant-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=assessments
- `alpha://company/immunovant-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- NO_RECORDS_FOUND

## Leadership

- Frank M. Torti: Executive Chairperson of the Board. Claim: alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:99befad37c3be170a575d02ec3cf0bdf77c31c1724a8c69d224fd8235a00fd1b.
- Andrew Fromkin: Director. Claim: alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:99befad37c3be170a575d02ec3cf0bdf77c31c1724a8c69d224fd8235a00fd1b.
- Atul Pande: Director. Claim: alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:99befad37c3be170a575d02ec3cf0bdf77c31c1724a8c69d224fd8235a00fd1b.
- Douglas Hughes: Director. Claim: alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:99befad37c3be170a575d02ec3cf0bdf77c31c1724a8c69d224fd8235a00fd1b.
- Jacob Bauer: Director. Claim: alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:99befad37c3be170a575d02ec3cf0bdf77c31c1724a8c69d224fd8235a00fd1b.
- Robert Susman: Director. Claim: alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:99befad37c3be170a575d02ec3cf0bdf77c31c1724a8c69d224fd8235a00fd1b.
- Christopher Van Tuyl: Chief Legal Officer and Corporate Secretary. Claim: alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:99befad37c3be170a575d02ec3cf0bdf77c31c1724a8c69d224fd8235a00fd1b.
- Eric Venker: Chief Executive Officer. Claim: alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:99befad37c3be170a575d02ec3cf0bdf77c31c1724a8c69d224fd8235a00fd1b.
- Eric Venker, M.D., Pharm.D.: Chief Executive Officer. Claim: alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:14. Valid from: 2025-07-09. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bcab2a0963fd997c99655171e197fff8c44f5282461c5259374b569dbefa9d83.
- Jay S. Stout: Chief Technology Officer. Claim: alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:99befad37c3be170a575d02ec3cf0bdf77c31c1724a8c69d224fd8235a00fd1b.
- Jay S. Stout, Ph.D.: Chief Technology Officer. Claim: alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:16. Valid from: 2025-07-09. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f10c9ddb196040232cd089bffd25bfe514d6f3104e3332476d44631b8e1c5ba4.
- Melanie Gloria: Chief Operating Officer. Claim: alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:99befad37c3be170a575d02ec3cf0bdf77c31c1724a8c69d224fd8235a00fd1b.
- Michael Geffner, M.D.: Chief Medical Officer. Claim: alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:18. Valid from: 2025-07-09. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:81ab1bee7de9376cdbf85c70d0a10e411359419b5b33fa599d867e606f2f70f6.
- Tiago Girao: Chief Financial Officer. Claim: alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:19. Valid from: 2025-07-09. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6cb1bc320b146b1de91881594a0c24a177a558ace873a47edd7e2002a1bab725.
- Tiago Girão: Chief Financial Officer. Claim: alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:99befad37c3be170a575d02ec3cf0bdf77c31c1724a8c69d224fd8235a00fd1b.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- PUBLISHED

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Immunovant, Inc.. Claim: alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c81580f4b1c3a7125424bc87f2b0f1720b7db013f8476ca21546925a609063ba.

## Entity Status

- Public listing published. Claim: alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c81580f4b1c3a7125424bc87f2b0f1720b7db013f8476ca21546925a609063ba.

## Published Fact

- US. Claim: alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c81580f4b1c3a7125424bc87f2b0f1720b7db013f8476ca21546925a609063ba.
- Healthcare. Claim: alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c81580f4b1c3a7125424bc87f2b0f1720b7db013f8476ca21546925a609063ba.

## Security Listing

- IMVT (NASDAQ). Claim: alpha:claim:company:475a2678-8a75-462d-b44c-64017cac3e77:security_listing:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c81580f4b1c3a7125424bc87f2b0f1720b7db013f8476ca21546925a609063ba.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:c81580f4b1c3a7125424bc87f2b0f1720b7db013f8476ca21546925a609063ba: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/immunovant-inc).
- alpha:projection-evidence:document:99befad37c3be170a575d02ec3cf0bdf77c31c1724a8c69d224fd8235a00fd1b: [SEC DEF 14A 0001764013-26-000092](https://www.sec.gov/Archives/edgar/data/1764013/000176401326000092/imvt-20260721.htm).
- alpha:projection-evidence:document:bcab2a0963fd997c99655171e197fff8c44f5282461c5259374b569dbefa9d83: [IMVT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1764013/000176401325000103/imvt-20250709.htm).
- alpha:projection-evidence:document:f10c9ddb196040232cd089bffd25bfe514d6f3104e3332476d44631b8e1c5ba4: [IMVT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1764013/000176401325000103/imvt-20250709.htm).
- alpha:projection-evidence:document:81ab1bee7de9376cdbf85c70d0a10e411359419b5b33fa599d867e606f2f70f6: [IMVT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1764013/000176401325000103/imvt-20250709.htm).
- alpha:projection-evidence:document:6cb1bc320b146b1de91881594a0c24a177a558ace873a47edd7e2002a1bab725: [IMVT DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1764013/000176401325000103/imvt-20250709.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/immunovant-inc)
- [Public Markdown](https://registry.alpha.ac/companies/immunovant-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/immunovant-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/immunovant-inc?format=jsonld)
- MCP resource: `alpha://companies/immunovant-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-21T21:41:21.119243+00:00; recorded 2026-10-21T21:41:21.119243+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.